Clinical studies are complex, expensive and multidisciplinary. There are many clinical CRO's to choose from.

Antaeus Biopharma can assist in developing and managing the key elements of early phase studies (1a, 1b, 2), including CRO selection, auditing and managing study conduct. This will avoid you setting up your own early-phase clinical organization and gives you flexibility in cost allocation and resource planning.

We tap from a wide experience of clinical conduct, including phase 1a, 1b, and phase 2 with multiple different study objectives:

- safety & tolerability studies incl. SAD and MAD

- ADME studies, e.g. human mass balance studies including metabolite profiling studies (radiochemical, elemental)

- PK studies, e.g. BE studies, interaction studies & food-effect studies

- POC/POP studies, biomarker studies

- One-off studies, e.g. phase 0